Skip to content

Iqvia Holdings Inc.

Iqvia Holdings

IQV · NYSE

Healthcare

Catalog as of September 15, 2026. Not a live market feed.

Fiscal Year
2025
Revenue
$16.3B
Assets
$29.9B
SEC filing
DEF 14A
Filed
February 27, 2026

Executive Compensation

Compensation reported for Iqvia Holdings’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.

Ari Bousbib

Chairman And Chief Executive Officer

$28.1M

Reported total · FY2025 · SCT Total as filed

Source: DEF 14A Summary Compensation Table, filed February 27, 2026.

Salary
$1.8M
Stock Awards
$15.7M
Option Awards
$4.5M
Incentives
$5M
Other
$1.1M

Historical Compensation

Ari Bousbib total compensation, fiscal years 2023–2025.

Year-by-year total compensation
Fiscal YearSalaryTotal Compensation
2025$1,800,000$28,128,245
2024$1,800,000$26,732,998
2023$1,800,000$29,151,752

Named Executive Officers

Source information

Company
Iqvia Holdings Inc.
Ticker
IQV · NYSE
Filing type
DEF 14A
Fiscal year
2025
Filing date
February 27, 2026
SEC accession number
0001628280-26-012892

Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing

Related Companies